8-iso-PGE2,
8-isoprostaglandin E2,
8-Iso-PGE2,
8-isoprostaglandin E2,
UNII-W1ANC8Q5NW,
W1ANC8Q5NW,
27415-25-4,
8-iso PROSTAGLANDIN E2,
9-oxo-11R,15S-dihydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R],
Prosta-5,13-dien-1-oic acid, 11,15-dihydroxy-9-oxo-, (5Z,8beta,11alpha,13E,15S)-,
7-[3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-heptenoic acid,
8-epi-PGE2,
8-epi-prostaglandin E2,
AC1NR1RW,
SCHEMBL14510009,
CHEBI:131888,
XEYBRNLFEZDVAW-CLQOMRTCSA-N,
HMS3648F19,
LMFA03110003,
ZINC12496636,
LS-174182,
SR-01000946422,
SR-01000946422-1,
(5Z,8b,11a,13E,15S)-11,15-dihydroxy-9-oxo-Prosta-5,13-dien-1-oate,
7-[3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentyl]-5-Heptenoate,
(5Z,8b,11a,13E,15S)-11,15-dihydroxy-9-oxo-Prosta-5,13-dien-1-oic acid,
(5Z,8beta,11alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid,
(Z)-7-[(1S,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]hept-5-enoic acid,
FA(20:2(OH2,Ke,cyclo)),
C20H32O5,
C20-H32-O5,
CID5283213,
C011987,